Chlamydia Trachomatis: Clinical Trials

3 trials for Chlamydia Trachomatis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Chlamydia Trachomatis: new trials by email Literature Review of Chlamydia Trachomatis trials Research Report on Chlamydia Trachomatis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger
Azithromcyin, Azithromycin - Trachoma, Chlamydia Trachomatis
Phase 4CompletedUniversity of California, San Francisco11392008-01-012012-05-08
Washington State Community Expedited Partner Treatment (EPT) Trial
Patient delivered partner therapy, Targeted public health partner services - Gonorrhea, Neisseria Gonorrhoeae
Phase 4CompletedUniversity of Washington332222007-07-012012-08-17
Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers
Monthly antibiotic, Monthly placebo - Neisseria Gonorrhoeae Infection, Chlamydia Trachomatis
Phase 4CompletedCHU de Quebec-Universite Laval6362001-03-012013-02-13

Narrower conditions

Gonorrhea (2)  ·  Chlamydia Infections (1)  ·  Sexually Transmitted Diseases (1)  ·  Trachoma (1)

Broader conditions

Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Gram-Negative Bacterial Infections (3)  ·  Infections (3)  ·  Chlamydiaceae Infections (2)  ·  Communicable Diseases (2)  ·  Genital Diseases (2)  ·  Neisseriaceae Infections (2)  ·  Sexually Transmitted Diseases, Bacterial (2)  ·  Urogenital Diseases (2)  ·  Chlamydia Infections (1)  ·  Conjunctival Diseases (1)  ·  Conjunctivitis (1)  ·  Conjunctivitis, Bacterial (1)  ·  Corneal Diseases (1)

Interventions

Azithromycin (2)  ·  Ciprofloxacin (1)

Sponsors

CHU de Quebec-Universite Laval (1)  ·  University of California, San Francisco (1)  ·  University of Washington (1)

Countries

United States (2)  ·  Benin (1)  ·  Niger (1)

Top investigators

Abdou Amza, MD (1)  ·  Julius Schachter, PhD (1)  ·  Matthew Golden, MD (1)  ·  Michel Alary, MD, PhD (1)

Results publications

PMID 22421690, PMID 25590331

NIH funding

R01AI048789 (1), R01AI068107 (1)